Authors
Loading...
Multi-omics study reveals a brain radiotoxicity gene signature predicts survival in glioblastoma, highlighting potential targets for neuro-oncology drug repositioning.
Reyes-González et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: